WhiteOak Capital Multi Cap Fund
The Scheme seeks to provide long-term capital appreciation / income by investing across market capitalisations and managing a diversified portfolio of Large Cap, Mid Cap and Small Cap Stock.
Growthvine rating: 4/5 — ranked #6 of 34 in category.
Fund basics
| Category | Equity: Multi Cap |
|---|
| NAV | ₹16.46 (as of 2026-11-13) |
|---|
| AUM | ₹4,610 Cr |
|---|
| Expense ratio | 1.62% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Ramesh Mantri |
|---|
| Exit load | 0 |
|---|
Performance & risk
| Sharpe ratio | 0.66 |
|---|
| Standard deviation | 15.66% |
|---|
| Max drawdown | −17.21% |
|---|
| Alpha | 6.63 |
|---|
| Beta | 0.9 |
|---|
Over 5 years, captured 106.6% of NIFTY500 Multicap 50:25:25's upside and 86.6% of its downside.
Market cap allocation
| Large cap | 38.1% |
|---|
| Mid cap | 27.9% |
|---|
| Small cap | 34.0% |
|---|
Concentration
| Top 5 holdings | 15.0% |
|---|
| Top 10 holdings | 22.5% |
|---|
| Total holdings | 193 |
|---|
| Index overlap | 40.0% |
|---|
| Active share | 60.0% |
|---|
Top holdings
- ICICI Bank Ltd. — 5.5%
- Clearing Corporation of India Ltd — 3.6%
- Bharti Airtel Ltd. — 3.3%
- Nestle India Ltd. — 2.3%
- Eternal Limited — 2.0%
- HDFC Bank Ltd. — 1.9%
- State Bank Of India — 1.7%
- Mahindra & Mahindra Ltd. — 1.6%
- Nexus Select Trust — 1.6%
- Kotak Mahindra Bank Ltd. — 1.5%
Top sectors
- Banking & Financial — 18.8%
- Pharma & Biotech — 7.4%
- Finance & Investments — 7.1%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 6.6% | Q2 | #16 of 33 |
| 2025 | 5.6% | Q1 (Top) | #6 of 30 |
| 2024 | 28.6% | Q1 (Top) | #5 of 23 |